Indications for the use of diagnostic implantable and external ECG loop recorders
Year: 2009
Type: article
Abstract: ECG loop recorders have a retrospective (loop) memory which continuously records and deletes the patient's ECG. They include a patient-activation function that allows the patient to activate ECG storage as a result of symptoms and an auto-activation feature that allows the capture of arrhythmic events without relying on patient compliance or perception of symptoms. Loop recorder devices can be both implantable (ILR) and external (ELR). Table 1 summarizes the characteristics of the most common diagnostic loop recorders. The retrospective memory differentiates loop recorders from prospective-only event recorders. While event recorders have some usefulness in patients with intermittent palpitations, they have no indication to detect syncope. Most common implantable and external loop recorders a, coming soon (not yet available); b, mobile cardiac outpatient telemetry; c, depends on Memory Card capacity. *Monitoring duration is determined by the battery longevity for implantable devices and by average maximum patients' compliance for external devices. Most common implantable and external loop recorders a, coming soon (not yet available); b, mobile cardiac outpatient telemetry; c, depends on Memory Card capacity. *Monitoring duration is determined by the battery longevity for implantable devices and by average maximum patients' compliance for external devices. Knowledge of what occurs during a spontaneous event is the ideal gold standard for evaluation. Patients with infrequent short-duration transient symptoms, recurring over weeks or months, are unlikely to be diagnosed by conventional Holter monitoring, since the likelihood of symptom-ECG correlation is very low. Consideration should be given to patient-activated event recording in such patients, but this technique has important limitations that might prevent a successful ECG recording of the event, especially for those with syncope, as it implies the activation of recording by the patients once the patient has already recovered consciousness. In such circumstances, consideration should be given to implantable and external ECG loop recorders. It is likely that loop recorders will become increasingly important, and their use will increasingly be appropriate instead of, or before, many current conventional investigations. This early loop recorder approach implies, on the one hand, the need for careful initial risk stratification in order to exclude from such a strategy patients with potential life-threatening conditions that require immediate hospitalization or intensive evaluation and treatment. On the other hand, as a general rule ECG loop recorders are indicated only when there is a high pre-test probability of identifying an heart rhythm abnormality responsible of symptoms. These conditions will be discussed in the document. Ultimately, technology may allow recording of multiple signals in addition to the ECG (e.g. blood flow or pressure, EEG, etc.) and the automatic immediate wireless transmission of pertinent data to a central monitoring station. Such advances will permit greater emphasis on the documenting and characterizing of spontaneous episodes. Conversely, they will result in less reliance for current diagnostic testing techniques that are largely designed to assess susceptibility to the provocation of syncope or palpitations in the laboratory. The Task Force has classified and ranked the usefulness or efficacy of the recommended procedure and/or treatments and the level of evidence as indicated in the tables below: The Task force was unable to give formal recommendations for non-established indications, i.e. atrial fibrillation and risk stratification, due to the lack of sufficient trial-based evidence. In these fields, loop recorders remain very interesting research tools. Clinical evaluation is enough to establish a likely mechanism of syncope in the majority of patients Exclude high-risk patients, i.e. those with a clear indication for ICD, pacemaker, or other treatments independent of a definite diagnosis of the cause of syncope Be aware that the pre-test selection of the patients influences the subsequent findings. Include patients with a high likelihood of arrhythmic events Include patients with a high probability of recurrence of syncope in a reasonable time period Due to the unpredictability of syncope recurrence, be prepared to wait for a substantial time before obtaining such a correlation Your ideal goal should be to obtain a correlation ECG and are Clinical evaluation is enough to establish a likely mechanism of syncope in the majority of patients Exclude high-risk patients, i.e. those with a clear indication for ICD, pacemaker, or other treatments independent of a definite diagnosis of the cause of syncope Be aware that the pre-test selection of the patients influences the subsequent findings. Include patients with a high likelihood of arrhythmic events Include patients with a high probability of recurrence of syncope in a reasonable time period Due to the unpredictability of syncope recurrence, be prepared to wait for a substantial time before obtaining such a correlation Your ideal goal should be to obtain a correlation ECG and are is in the general and of the general of an of of during of one of with a the of and increasingly the of In the for the of syncope a from events in to in 1 only of these in a and an some evaluation. of this can be in the the of this the of the of syncope recurrence the duration of the loop weeks for external and to for implantable for an appropriate selection of the for these diagnostic of of and their are the of Table recurrence in patients without heart and and the probability in the of patients in the 1 and by syncope or syncope. Conversely, of and or of heart have or on probability of syncope recurrence and are for the selection of the the of heart the likelihood of of an which will have of patients with of from and of patients with of from and of patients with diagnosis and risk the of during a a of patients with diagnosis and risk the of during a a of patients with diagnosis and risk the of during the a a of patients with diagnosis and risk the of during the a a In the initial the was for diagnosis in patients with syncope the of conventional In a of patients, correlation was in of patients a of of data from for a of patients with syncope the of a conventional that a correlation syncope and ECG was in patients of these in the time of the event, and no 1 In data from was less likely to be with an syncope some to be an for syncope in a diagnosis is only during that is for syncope. The diagnostic of was by the to a in to of the patients of the the and automatic of the and by in the most devices. in patients with syncope and implantable loop recorder the of conventional and in patients with syncope and implantable loop recorder early initial evaluation. The majority of ECG the time of with many events The majority of The correlation of a ECG with a spontaneous syncope can be as the gold that this is in episodes. are data on of in the data from and patients by of due to an in of these the during the was the that during the syncope. These data in the majority of patients, the or of an during the syncope can be a diagnostic and a can be the of and the data be as the initial in patients with syncope, it that the might become the standard to be when an arrhythmic cause of syncope is but to allow an treatment. are in which to be These when was in patients with syncope the of the conventional and when was in patients with syncope in an early the initial evaluation 1 In both a due to or due to on average in duration was the most syncope in the of cardiac Patients with in a is likely a in these patients, a the most is an intermittent which was by in of the events a of these in the in which an intermittent that was by was in of the these patients only and of the patients the of the mechanism of syncope in those patients have recurrence during the Patients with definite heart in an is likely a Patients with when the of the mechanism of spontaneous syncope is to a In patients in a cardiac cause of syncope is due to heart or in data on patients from a diagnosis was in of of these a or the time of the event, and no but of patients have a likely diagnosis of syncope the initial or during in order to capture an event when cardiac be by the and unpredictability of symptoms and lack of of syncope Patients in was but the has and in patients with in order to detect cardiac that require Patients with and of in order to exclude an arrhythmic cause of In patients with to establish the of the event The diagnostic was in patients with and without heart in the of in the of and in the of While patients with and without heart of syncope recurrence, mechanism was patients with heart and and patients without heart or no on the other the patients with only arrhythmic patients with heart an The diagnostic was in the In one the patients a syncope recurrence those and likely to have an time of syncope of with was by that of patients with syncope the of a conventional to of patients for evaluation to a syncope have an indication for the need for in the general was to be this to the indication for patients those by syncope, of syncope in or and the need for to This is of since a correlation with the syncope allow the use of or as of the mechanism of syncope, to the diagnostic and/or to without for of a with the patient in order to the of the of a In the of the patients with an during in patients and in the during on the in patients without during an when they a in the of the patients with patients an as or and of the during the on the in of patients without during a during the syncope. was with classified as in the In the patients with the time of events and the other of In the patients with only a syncope and the no the time of the syncope. the of a during or has a for the diagnosis of the mechanism of syncope. In the of an or a patient-activated or the mechanism of syncope, the strategy of these as diagnostic findings. The of these is in and by with other of ECG monitoring and in current the of an or a in the the diagnostic have by to and diagnosis have on average by in of diagnosis by of syncope. this force that these for and are both largely auto-activation feature the diagnostic this feature can be by the of and the of of storage in include to in during both rhythm and by transient of ECG to and of a of from patients with the that a of of by the and of patients one or episodes. most of these can be they can with of The of is data the of are of is a of the risk of that with This which can in the or during the was in a of 1 to of the of the of and the of rhythm with the the time of syncope, the have a that the in order to an for and Table 1 was the most that was in of was in of or rhythm was in of and was in of This has become and by The has some which are to of arrhythmic syncope and have and In and the of most by due to or by due to that the syncope is In the of due to with in of the as in In and a cardiac is responsible for syncope. In the other in which no is the of syncope of the lack of recording of blood the of heart and/or the time of syncope a or activation of the and a The of spontaneous syncope or initial by by with in with in with in of heart or for of heart for or rhythm of heart and heart or in heart in heart but and but and of heart and heart fibrillation or initial by by with in with in with in of heart or for of heart for or rhythm of heart and heart or in heart in heart but and but and of heart and heart fibrillation The of spontaneous syncope or initial by by with in with in with in of heart or for of heart for or rhythm of heart and heart or in heart in heart but and but and of heart and heart fibrillation or initial by by with in with in with in of heart or for of heart for or rhythm of heart and heart or in heart in heart but and but and of heart and heart fibrillation In the initial the was as in the evaluation of syncope have a correlation the of and and the ECG the time of spontaneous syncope In other the and of some of the most important for diagnosis on their in the diagnostic the diagnostic of ECG monitoring external loop have an early of the soon in an initial of the diagnostic patients with syncope to testing with external loop recorder and and testing or to monitoring with the The that a strategy of of the loop recorder in an initial of the is likely to a diagnosis conventional testing during a patients high risk of life-threatening as those with an of These in the in patients a to the or conventional and The patients a probability of a diagnosis when with the conventional during a of in the and in the conventional early the initial evaluation was in the in patients with syncope. Patients with heart diagnosis was in of the patients during a of the patients of these due to arrhythmic due to and due to to syncope in and in In the that early can be in the initial of the diagnostic that patients risk of life-threatening events are to the of syncope of the of the patients risk require immediate hospitalization and intensive evaluation can be the initial evaluation Table In these risk are an strategy can be in the patients risk for arrhythmic syncope have a of syncope of high risk of or high of which can of a In the less evaluation is sufficient to establish a likely mechanism of syncope in the majority of patients and no is Patients risk for arrhythmic syncope are for the of the usefulness of is largely as a general is indicated when the probability of syncope recurrence during the longevity of the battery is and when the of a correlation is for the patients with an indication for implantable to should this The monitoring function of the can be to the mechanism of syncope. the patients with and should an which should be only the of a the patients with or that an intermittent should monitoring and an should be the of a high-risk that require immediate hospitalization or early intensive evaluation as appropriate on syncope in which there is a clear indication for or of a definite diagnosis of the cause of syncope to or or or Clinical or ECG an arrhythmic during or the time of syncope of duration or in the of or with in in and of in which there is a clear indication for or of a definite diagnosis of the cause of syncope to or or or Clinical or ECG an arrhythmic during or the time of syncope of duration or in the of or with in in and of high-risk that require immediate hospitalization or early intensive evaluation as appropriate on syncope in which there is a clear indication for or of a definite diagnosis of the cause of syncope to or or or Clinical or ECG an arrhythmic during or the time of syncope of duration or in the of or with in in and of in which there is a clear indication for or of a definite diagnosis of the cause of syncope to or or or Clinical or ECG an arrhythmic during or the time of syncope of duration or in the of or with in in and of flow is in The recommended and diagnostic are in the loop recorder in the of transient of is the In the on a the patients to an diagnostic and treatments conventional a only be to a of patients, the a in events with of is the most the time of syncope recurrence, cardiac is the most in In the initial to was in of patients In data of patients from a was in of patients of those an This from in patients with syncope to in the patients with a data are on the subsequent In cardiac syncope in patients with but prevent the of syncope. In the the of syncope from in the of patients without to in the patients with a risk In the of the of a cardiac pacemaker, syncope from to in patients with or ECG of the and from to in the syncope In data of patients from an and in 1 and of the patients and atrial in in patients with atrial fibrillation and The of for diagnosis of and infrequent symptoms such as syncope is that the patients continuously external in order to activate loop The to have in patients with spontaneous symptoms are likely to This time is the maximum that a patient can duration diagnostic can be the that documenting an ECG during will the mechanism of syncope. are to those for but the patient selection depends on the of the probability of recurrence and diagnostic are the as for In to a diagnostic conventional evaluation or Holter monitoring but syncope over or the for are to patients with high probability of recurrence in a very The diagnostic in such patients is low. In one patients with a of during the and no heart only 1 be by which In patients with a of during a diagnosis was in a diagnosed in loop recorders to be when symptoms in addition to and less are in order to exclude an arrhythmic cause of symptoms. in an correlation was in of patients but an was in only 1 patient it be in the other In a a correlation was in and of correlation was in of these and when an was in the a of are It should be in of of correlation with their is and monitoring should be diagnosis is by In an early of evaluation of patients with syncope of of high-risk that require immediate hospitalization or intensive i.e. those in the Table and likely recurrence battery longevity of the of evidence In high-risk patients in a evaluation in Table a cause of syncope or to of evidence assess the of before on cardiac in patients with or syncope with or of evidence In patients with of in order to exclude an arrhythmic mechanism of evidence of and of arrhythmic and of high-risk that require immediate hospitalization or intensive i.e. those in Table of evidence and are diagnostic correlation syncope and an or is of evidence the of such of or or a for during patients or atrial or for atrial or are of evidence and exclude an arrhythmic cause when there is no correlation syncope and rhythm of evidence without as those of evidence those of evidence of of evidence In an early of evaluation of patients with syncope of of high-risk that require immediate hospitalization or intensive i.e. those in the Table and likely recurrence battery longevity of the of evidence In high-risk patients in a evaluation in Table a cause of syncope or to of evidence assess the of before on cardiac in patients with or syncope with or of evidence In patients with of in order to exclude an arrhythmic mechanism of evidence of and of arrhythmic and of high-risk that require immediate hospitalization or intensive i.e. those in Table of evidence and are diagnostic correlation syncope and an or is of evidence the of such of or or a for during patients or atrial or for atrial or are of evidence and exclude an arrhythmic cause when there is no correlation syncope and rhythm of evidence without as those of evidence those of evidence of of evidence are for palpitations for syncope evaluation are less indicated records may be only when symptoms enough to allow the patient to activate the recorder The diagnostic of loop recorders is are for palpitations for syncope evaluation are less indicated records may be only when symptoms enough to allow the patient to activate the recorder The diagnostic of loop recorders is a very common for which They may be due to cardiac from atrial and to atrial and or to to such as and In especially in patients with infrequent symptoms, a diagnosis is to establish in of careful evaluation that standard ECG and Holter The usefulness of event recorders which are or by the patient is by the that they are unable to detect the mechanism of of the and by the lack of automatic the of palpitations a correlation symptoms and ECG can be by the of and patients with palpitations can be on high-risk patients may need hospitalization and to rule life-threatening are in Table on On the other hand, some patients with and symptoms and no cardiac can be and without a diagnosis be the patients risk with and or symptoms are the for loop recorders. They are to since they are of recording retrospective and ECG by the they allow automatic recording of is monitoring be for patients with recurrence of palpitations the ideal can be for a as as event when the duration of is enough to allow the of the by the patient In in which patients with recurrence of palpitations, as as event recorders a diagnostic of to that of conventional Holter to the of palpitations in patients, the most are atrial and and atrial and are less palpitations are for for syncope evaluation. In a of patients by palpitations, or syncope, with an of in and of the correlation was in those with palpitations, and syncope. loop due to their and a in patients with palpitations when with those with syncope. They may be in patients with infrequent palpitations with when other result are on the use of in patients with In the patients with infrequent and Patients to conventional strategy Holter a period of ECG monitoring with an external and or to with diagnosis was in patients in the conventional strategy and in in the the initial the diagnosis in the was in the conventional strategy a diagnosis was patients for in patients with arrhythmic diagnosis with pacemaker, or The and for and are in Table and for event and from and for event and from for syncope, the gold standard for loop recorder use is the correlation ECG and symptoms. The of the technique is high when an is during symptoms. rhythm during palpitations an arrhythmic The of loop recorders is and depends on that include monitoring technique and of symptoms, and patient and are diagnostic when a correlation and an is level of evidence and exclude an arrhythmic cause when there is no correlation and rhythm level of evidence and are diagnostic when a correlation and an is level of evidence and exclude an arrhythmic cause when there is no correlation and rhythm level of evidence is a correlation of symptoms with atrial fibrillation especially rhythm is which evaluation of the of are potential for in to the efficacy of rhythm in rhythm when from is the to the of is by intermittent monitoring monitoring by implantable devices the of but it is by and are for of can diagnostic are The of some with devices are The of Loop to and has yet to be is a correlation of symptoms with atrial fibrillation especially rhythm is which evaluation of the of are potential for in to the efficacy of rhythm in rhythm when from is the to the of is by intermittent monitoring monitoring by implantable devices the of but it is by and are for of can diagnostic are The of some with devices are The of Loop to and has yet to be While techniques are for of ECG monitoring the in the efficacy of rhythm in to the efficacy of rhythm is to have that the and duration of are and a there is a correlation of symptoms with without or symptoms, in In some patients, palpitations due to or may to and of may the perception of the In as as in the of was to during and patients of a during a Holter is a correlation the symptoms and of from are potential for a of rhythm can be with or intermittent monitoring Holter to and event recorders with or without loop In rhythm the of is a and a for a of it is to symptoms with ECG especially when the of symptoms is potential are the for in patients to and the evaluation of the efficacy of the rhythm the of these indication of has yet to be that the risk is by the of and In one but was with that the risk by can be by with of events the to duration of with or duration from to with or duration with It is that the likelihood of as as with the duration of the monitoring the duration of Holter from to the of approach is the use of the for ECG recording recording during of symptoms. both and may be Most the ECG or some the data on a memory The is to the and is only the for the ECG recording time of The of the it for that are to assess of the event recorder is to on the duration of episodes. for of 1 monitoring as Holter ECG the current on rhythm in to detect by Holter monitoring or ECG In patients should be with an event this one has to that with the monitoring no of will be loop recorder is ideal for of when it to an event recorder or for ECG of that are with symptoms such as syncope. ECG recording is to the or by the require of on the for activation of the loop This to be only by patients for a period of 1 with a maximum of have indicated that compliance is when patients are to use for Such a recording is for of rhythm in patients with the no for this in patients, the may to symptoms with of over a period of with monitoring is from of data in implantable devices such as and with an atrial They allow of by the and duration of episodes. of their duration or symptoms can be of data has that intermittent Holter recording with monitoring recurrence the of the data depends on the of due to and atrial may of and duration of episodes. In an of of to be from due to or are for of only monitoring is to the of and episodes. of the correlation strategy and the of has by intermittent with monitoring by that of have with 1 Holter this most of recurrence is only in the of or correlation strategy and the of atrial fibrillation loop recorders a in patients with infrequent symptoms and The an of monitoring of heart rhythm and use in patients to of In an of patients, of patient-activated for a of in most in a symptoms and was of ECG to be from due to The of the is a lack of automatic that of and the no in The of the Table 1 automatic on rhythm the have to the of this to detect This of the with Holter In patients, the is designed to the of by the with standard of and especially are patients with function and patients with have a high risk of are for research and of cardiac The usefulness of to and in patients has yet to be have a potential in identifying the correlation symptoms and in high-risk patients by ECG or and and especially are patients with function and patients with have a high risk of are for research and of cardiac The usefulness of to and in patients has yet to be have a potential in identifying the correlation symptoms and in high-risk patients by ECG or and and research ECG loop recorders has on patients, especially patients with syncope, documenting the arrhythmic of symptoms. The a research for in patient and was designed to the and of cardiac in patients with In this and/or in patients during a of these The a of duration and was by and was with an risk of cardiac during the in documenting events as a of risk stratification weeks
Source: EP Europace
Authors: Task Force members, M. Brignole, P. Vardas, E. Hoffman, H. Huikuri, A. Moya, R. Ricci, N. Sulke, W. Wieling, A. Auricchio, G. Y.H. Lip, J. Almendral, P. Kirchhof, E. Aliot, M. Gasparini, F. Braunschweig, Document Reviewers, G. Y.H. Lip, J. Almendral, P. Kirchhof, G. L. Botto
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1994609836
